Loading...

Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer

Incidence of infusion related reaction (IR) is more common with cetuximab (Cmab) than with panitumumab (Pmab). Although little is known about rechallenge IR with monoclonal antibodies, we experienced a successful rechallenge to Cmab after IR to Pmab. A 67-year-old female patient was scheduled for ch...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int Cancer Conf J
Main Authors: Yokokawa, Hideyuki, Kono, Teppei, Shidei, Hiroaki, Oyama, Kunihiro, Ito, Yoshitomo, Imaizumi, Rie, Miyano, Yutaka, Shiozawa, Shunichi, Yoshimatsu, Kazuhiko
Format: Artigo
Sprog:Inglês
Udgivet: Springer Singapore 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797389/
https://ncbi.nlm.nih.gov/pubmed/33489709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00455-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!